Lerner SP - Search Results

1

Centrosomal abnormality is common in and a potential biomarker for bladder cancer.

Jiang F, Caraway NP, Sabichi AL, Zhang HZ, Ruitrok A, Grossman HB, Gu J, Lerner SP, Lippman S, Katz RL. Jiang F, et al. Among authors: lerner sp. Int J Cancer. 2003 Sep 20;106(5):661-5. doi: 10.1002/ijc.11251. Int J Cancer. 2003. PMID: 12866024

2

Two molecular pathways to transitional cell carcinoma of the bladder.

Spruck CH 3rd, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmütte C, Yang AS, Cote R, et al. Spruck CH 3rd, et al. Among authors: lerner sp. Cancer Res. 1994 Feb 1;54(3):784-8. Cancer Res. 1994. PMID: 8306342

3

Role of chromosome 9 in human bladder cancer.

Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH 3rd, Gonzalez-Zulueta M, Nichols PW, Skinner DG, Jones PA. Miyao N, et al. Among authors: lerner sp. Cancer Res. 1993 Sep 1;53(17):4066-70. Cancer Res. 1993. PMID: 8358736

4

Retinoids in the chemoprevention of bladder cancer.

Sabichi AL, Lerner SP, Grossman HB, Lippman SM. Sabichi AL, et al. Among authors: lerner sp. Curr Opin Oncol. 1998 Sep;10(5):479-84. doi: 10.1097/00001622-199809000-00019. Curr Opin Oncol. 1998. PMID: 9800121 Review.

5

Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients.

Tokunaga H, Lee DH, Kim IY, Wheeler TM, Lerner SP. Tokunaga H, et al. Among authors: lerner sp. Clin Cancer Res. 1999 Sep;5(9):2520-5. Clin Cancer Res. 1999. PMID: 10499628

6

Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.

Shariat SF, Weizer AZ, Green A, Laucirica R, Frolov A, Wheeler TM, Lerner SP. Shariat SF, et al. Among authors: lerner sp. Urology. 2000 Nov 1;56(5):735-40. doi: 10.1016/s0090-4295(00)00756-1. Urology. 2000. PMID: 11068290

7

Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.

Younes M, Juarez D, Lechago LV, Lerner SP. Younes M, et al. Among authors: lerner sp. Anticancer Res. 2001 Jan-Feb;21(1B):575-8. Anticancer Res. 2001. PMID: 11299807

8

Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder.

Kim JH, Shariat SF, Kim IY, Menesses-Diaz A, Tokunaga H, Wheeler TM, Lerner SP. Kim JH, et al. Among authors: lerner sp. Cancer. 2001 Sep 15;92(6):1475-83. doi: 10.1002/1097-0142(20010915)92:6<1475::aid-cncr1472>3.0.co;2-x. Cancer. 2001. PMID: 11745225

9

Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma.

Shariat SF, Kim JH, Andrews B, Kattan MW, Wheeler TM, Kim IY, Lerner SP, Slawin KM. Shariat SF, et al. Among authors: lerner sp. Cancer. 2001 Dec 15;92(12):2985-92. doi: 10.1002/1097-0142(20011215)92:12<2985::aid-cncr10175>3.0.co;2-5. Cancer. 2001. PMID: 11753975

10

Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.

Casella R, Shariat SF, Monoski MA, Lerner SP. Casella R, et al. Among authors: lerner sp. Cancer. 2002 Dec 15;95(12):2494-9. doi: 10.1002/cncr.10989. Cancer. 2002. PMID: 12467062 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters